Creatine for women in pregnancy for neuroprotection of the fetus

  • Protocol
  • Intervention

Authors

  • Emily Bain,

    1. The University of Adelaide, ARCH: Australian Research Centre for Health of Women and Babies, The Robinson Institute, Discipline of Obstetrics and Gynaecology, Adelaide, South Australia, Australia
    Search for more papers by this author
  • Dominic Wilkinson,

    Corresponding author
    1. Women's and Children's Hospital, Department of Neonatal Medicine, Adelaide, SA, Australia
    • Dominic Wilkinson, Department of Neonatal Medicine, Women's and Children's Hospital, 72 King William Road, Adelaide, SA, 5006, Australia. dominic.wilkinson@adelaide.edu.au.

    Search for more papers by this author
  • Philippa Middleton,

    1. The University of Adelaide, ARCH: Australian Research Centre for Health of Women and Babies, The Robinson Institute, Discipline of Obstetrics and Gynaecology, Adelaide, South Australia, Australia
    Search for more papers by this author
  • Caroline A Crowther,

    1. The University of Adelaide, ARCH: Australian Research Centre for Health of Women and Babies, The Robinson Institute, Discipline of Obstetrics and Gynaecology, Adelaide, South Australia, Australia
    2. The University of Auckland, Liggins Institute, Auckland, New Zealand
    Search for more papers by this author
  • Hayley Dickinson,

    1. Monash Institute of Medical Research, The Ritchie Centre, Melbourne, Victoria, Australia
    Search for more papers by this author
  • David W Walker

    1. Monash Institute of Medical Research, The Ritchie Centre, Melbourne, Victoria, Australia
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effects of creatine when used for neuroprotection of the fetus.